Skip to main content
. 2017 Feb 22;12(2):e0169830. doi: 10.1371/journal.pone.0169830

Fig 1. PTX3 and established markers of disease activity at baseline, 6 weeks and 6 months of treatment.

Fig 1

Values are given in median. IRD, inflammatory rheumatic disease; RA, rheumatoid arthritis; PsA, psoriatic arthritis; AS, ankylosing spondylitis; PTX3, pentraxin 3; WBC, white blood cells; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; PGA, Physicians Global Assessment Score of disease activity; PtGA, Patients' Global Assessment Score of disease activity. X p<0.01 for difference between the evaluation at baseline and at 6 weeks ¥ p<0.01 for difference between the evaluation at 6 weeks and 6 months.